Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

1.

Smoking, Genetics and Schizophrenia: Evidence for Self Medication.

Leonard S, Mexal S, Freedman R.

J Dual Diagn. 2007 Nov 1;3(3-4):43-59.

PMID:
19122786
[PubMed]
Free PMC Article
2.

Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.

Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, Ellis J, Zerbe GO, Leonard S, Stevens KE, Stevens JO, Martin L, Adler LE, Soti F, Kem WR, Freedman R.

Arch Gen Psychiatry. 2006 Jun;63(6):630-8.

PMID:
16754836
[PubMed - indexed for MEDLINE]
3.

Nicotinic receptors, smoking and schizophrenia.

Leonard S, Gault J, Adams C, Breese CR, Rollins Y, Adler LE, Olincy A, Freedman R.

Restor Neurol Neurosci. 1998 Jun;12(2-3):195-201.

PMID:
12671315
[PubMed]
4.

Evidence of association between smoking and alpha7 nicotinic receptor subunit gene in schizophrenia patients.

De Luca V, Wong AH, Muller DJ, Wong GW, Tyndale RF, Kennedy JL.

Neuropsychopharmacology. 2004 Aug;29(8):1522-6.

PMID:
15100704
[PubMed - indexed for MEDLINE]
Free Article
5.

Nicotinic agonists and psychosis.

Simosky JK, Stevens KE, Freedman R.

Curr Drug Targets CNS Neurol Disord. 2002 Apr;1(2):149-62. Review.

PMID:
12769624
[PubMed - indexed for MEDLINE]
6.

Schizophrenia and the alpha7 nicotinic acetylcholine receptor.

Martin LF, Freedman R.

Int Rev Neurobiol. 2007;78:225-46. Review.

PMID:
17349863
[PubMed - indexed for MEDLINE]
7.

[Smoking and schizophrenia: epidemiological and clinical features].

Dervaux A, Laqueille X.

Encephale. 2008 Jun;34(3):299-305. doi: 10.1016/j.encep.2007.04.003. Epub 2007 Dec 26. Review. French.

PMID:
18558153
[PubMed - indexed for MEDLINE]
8.

Smoking and schizophrenia: abnormal nicotinic receptor expression.

Leonard S, Breese C, Adams C, Benhammou K, Gault J, Stevens K, Lee M, Adler L, Olincy A, Ross R, Freedman R.

Eur J Pharmacol. 2000 Mar 30;393(1-3):237-42.

PMID:
10771019
[PubMed - indexed for MEDLINE]
9.

Schizophrenia, sensory gating, and nicotinic receptors.

Adler LE, Olincy A, Waldo M, Harris JG, Griffith J, Stevens K, Flach K, Nagamoto H, Bickford P, Leonard S, Freedman R.

Schizophr Bull. 1998;24(2):189-202. Review.

PMID:
9613620
[PubMed - indexed for MEDLINE]
Free Article
10.

P50 amplitude reduction: a nicotinic receptor-mediated deficit in first-degree relatives of schizophrenia patients.

Turetsky BI, Dent G, Jaeger J, Zukin SR.

Psychopharmacology (Berl). 2012 May;221(1):39-52. doi: 10.1007/s00213-011-2544-5. Epub 2011 Nov 3.

PMID:
22048129
[PubMed - indexed for MEDLINE]
11.

Smoking and mental illness.

Leonard S, Adler LE, Benhammou K, Berger R, Breese CR, Drebing C, Gault J, Lee MJ, Logel J, Olincy A, Ross RG, Stevens K, Sullivan B, Vianzon R, Virnich DE, Waldo M, Walton K, Freedman R.

Pharmacol Biochem Behav. 2001 Dec;70(4):561-70. Review.

PMID:
11796154
[PubMed - indexed for MEDLINE]
12.

Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.

Dalack GW, Healy DJ, Meador-Woodruff JH.

Am J Psychiatry. 1998 Nov;155(11):1490-501. Review.

PMID:
9812108
[PubMed - indexed for MEDLINE]
13.

Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia.

Zhang XY, Liu L, Liu S, Hong X, Chen da C, Xiu MH, Yang FD, Zhang Z, Zhang X, Kosten TA, Kosten TR.

Am J Psychiatry. 2012 Sep;169(9):974-81. doi: 10.1176/appi.ajp.2012.11081289.

PMID:
22952075
[PubMed - indexed for MEDLINE]
14.

Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.

Ochoa EL, Lasalde-Dominicci J.

Cell Mol Neurobiol. 2007 Aug;27(5):609-39. Review.

PMID:
17554626
[PubMed - indexed for MEDLINE]
15.
16.

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

Martin LF, Kem WR, Freedman R.

Psychopharmacology (Berl). 2004 Jun;174(1):54-64. Epub 2004 Feb 19. Review.

PMID:
15205879
[PubMed - indexed for MEDLINE]
17.

[Development of new therapeutic drugs based on the pathophysiology of schizophrenia].

Hashimoto K.

Seishin Shinkeigaku Zasshi. 2011;113(4):368-73. Japanese.

PMID:
21702128
[PubMed - indexed for MEDLINE]
18.

Nicotine use in schizophrenia: the self medication hypotheses.

Kumari V, Postma P.

Neurosci Biobehav Rev. 2005;29(6):1021-34. Review.

PMID:
15964073
[PubMed - indexed for MEDLINE]
19.

Schizophrenia and nicotinic receptors.

Freedman R, Adler LE, Bickford P, Byerley W, Coon H, Cullum CM, Griffith JM, Harris JG, Leonard S, Miller C, et al.

Harv Rev Psychiatry. 1994 Nov-Dec;2(4):179-92. Review.

PMID:
9384901
[PubMed - indexed for MEDLINE]
20.

Exogenous nicotine normalises sensory gating in schizophrenia; therapeutic implications.

Conway JL.

Med Hypotheses. 2009 Aug;73(2):259-62. doi: 10.1016/j.mehy.2009.02.017. Epub 2009 Mar 27.

PMID:
19328631
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk